
Whole Grains · Whole grain seed
Quinoa
Chenopodium quinoa · also called Quinua (Spanish), pseudocereal, pseudo-grain
Quinoa is the small seed of a plant from the Andes, cooked and eaten like a grain and counted with the whole grains. It gives fibre, protein, magnesium and manganese, and it is naturally gluten-free. Small trials link it to slightly better blood sugar and cholesterol, but the results are modest and mixed. The main cautions are gluten cross-contact if you have celiac disease, rare but real quinoa allergy, and the bitter saponin coating that is usually removed before sale.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Quinoa
Quinoa is the small seed of a plant native to South America. It is cooked and eaten like a grain and is counted with the whole grains because its structure is similar, though it is not a true cereal grass. It is a healthy food, not a proven remedy: the blood sugar and cholesterol findings come from a few small trials with modest, sometimes mixed, results.
What it is
Quinoa (Chenopodium quinoa) is an annual plant from the Andean regions of South America. Its small round seeds, sold white, red or black, are cooked and eaten like a grain. Its family is Amaranthaceae per GBIF, which makes it a relative of amaranth, beet and spinach rather than of wheat or rice.
USDA data for cooked quinoa: 120 kcal per 100 g. One cup (185 g) has about 222 kcal, 8.1 g protein, 5.2 g fibre, 118 mg magnesium, 1.17 mg manganese, 281 mg phosphorus, 78 micrograms folate (DFE), 2.8 mg iron and 318 mg potassium. Dry quinoa is much denser (368 kcal and 14.12 g protein per 100 g) because cooking adds water, so compare cooked with cooked. USDA lists no vitamin B12, vitamin C or vitamin K in cooked quinoa.
What the research shows
The firmest facts are about nutrients, and they are not trials of quinoa.
A pooled analysis of 7 trials (258 adults) reported a beneficial effect on fasting glucose at 15 to 50 g of quinoa a day, though its abstract gives no effect size. A one-year trial in 207 adults with impaired glucose tolerance found better blood sugar measures with quinoa than with mixed grains or no change. Pooled trials found tiny falls in triglycerides, total cholesterol and LDL, and a crossover trial of quinoa biscuits found LDL 0.25 mmol/L lower than wheat biscuits. But a 148-adult trial found no significant difference between quinoa, buckwheat, rice and bulgur, and weight results disagree between pooled analyses.
In 28 men, a small daily amount of quinoa flour did not change gut bacteria. Inflammation findings are from lab and animal studies only. Studies of whole grains in general link them to less heart disease, but those cannot prove cause and do not single out quinoa.
Food versus flour and saponin extracts
The trials here used quinoa seed, quinoa flour or foods made with it, such as biscuits and bread rolls. Some pooled analyses call this 'quinoa seed supplementation', but the amounts are food-sized. Saponin extracts are a lab topic and no human trial of them was read, so nothing here applies to extracts or supplements.
Portions
USDA lists one cup of cooked quinoa as 185 g, and one cup of dry quinoa as 170 g. Those are database portions, not advice. This page gives no amounts to eat. Ask a doctor, pharmacist or dietitian what is right for you, especially if you have celiac disease, a food allergy, kidney disease or take medicine for blood sugar.
At a glance
Traditional uses history, not proof
- A seed crop that reviews place in the Andean regions of South America
- Eaten cooked as a staple-style food; long use as food is not proof that it treats any condition
Studied for research
- Fibre, protein and minerals, high certainty for the nutrients, no trial of quinoa
- Blood sugar and insulin, low certainty (small trials; one head-to-head trial found no difference)
- Cholesterol and blood fats, low certainty (very small changes)
- Body weight, mixed (two pooled analyses disagree)
- Place in a gluten-free diet, low certainty (guidance, one small study, one lab study)
- Gut bacteria, insufficient evidence (one small trial found no change)
- Inflammation, very low certainty (lab and animal studies only)
- Long-term health, low certainty (observational, whole grains in general)
Main compounds
- Dietary fibre
- Protein
- Magnesium and manganese
- Saponins
- Carotenoids and vitamin E forms
Common forms
- Cooked whole quinoa seed (the USDA values are for this)
- Dry seed, flakes, flour and puffed quinoa (nutrient values mostly not read)
- Quinoa biscuits and bread rolls (used in two trials)
- Saponin extracts are a lab topic and are not the food
Research links: 2024 pooled analysis: quinoa, blood sugar and weight · 2025 trial: quinoa versus mixed grains in impaired glucose tolerance · 2014 study: quinoa in people with celiac disease · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Chenopodium quinoa
- Naming authority
- Willd. (GBIF accepted, usageKey 3083935)
- Common names
- Quinoa (English); Quinua (Spanish); Pseudocereal or pseudo-grain (English)
- Family or group
- Amaranthaceae per GBIF (older sources place quinoa in Chenopodiaceae, as one review abstract does). It is related to amaranth, beet and spinach, not to the cereal grasses.
- Classification
- Plantae > Tracheophyta > Magnoliopsida > Caryophyllales > Amaranthaceae > Chenopodium > Chenopodium quinoa
- Native range
- South America; the Andean regions (reviews of quinoa).
- Habitat
- Not verified from a source read beyond 'adaptable to different types of soils and climatic conditions' (Filho 2017 abstract).
- What it looks like
- Roots: Not verified.; Stems: Not verified.; Leaves: Not verified.; Flowers: Not verified.; Fruit: An annual plant grown for its small round seeds (sold white, red or black), eaten after cooking. Quinoa is counted with whole grains because its structure is similar to a cereal, but it is not a true cereal grass (Atefi 2024 and Li 2022 abstracts). USDA gives a household portion of 1 cup cooked = 185 g.
- Cultivation
- Not verified from a source read.
- Harvest and processing
- Sold as dry whole seed, flakes, flour or puffed seed (existing nutrient summary). The bitter saponin coating is usually removed before sale (Karydogianni 2026 abstract).
- Look-alikes and adulterants
- Name: Buckwheat and amaranth; Note: Other gluten-free pseudocereals with their own pages. Buckwheat was compared with quinoa in one 148-adult trial.; Name: Quinoa flour, flakes, puffed quinoa and saponin extracts; Note: Different products. Only the biscuit and bread trials used flour; extracts were not tested in people.
- Sustainability and conservation
- Not assessed.
Photographs

Traditional use and history history, not clinical proof
| Tradition or era | Documented use | Source |
|---|---|---|
| Andean South America | Reviews describe quinoa as an annual plant native to South America and originally from the Andean regions. No source read gives a date or traditional-use details. | p42589336; p26114306 (abstracts); detailed history NOT verified (no source read) |
Traditional use shows how it was used. It does not show that it works or is safe today.
What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Dietary fibre | carbohydrate | Seed USDA: 2.8 g per 100 g cooked; 7.0 g per 100 g dry | Provides fibre in the diet. Not tested here as a treatment. 26 25 | Composition data |
| Protein | protein | Seed USDA: 4.4 g per 100 g cooked; 14.12 g per 100 g dry | A review abstract describes a balance of essential amino acids; this was not checked against amino acid data. 26 5 | Composition data |
| Minerals (magnesium, manganese, copper, phosphorus) | minerals | Seed USDA per 100 g cooked: magnesium 64 mg, manganese 0.631 mg, copper 0.192 mg, phosphorus 152 mg | Nutrients the body needs. In a lab digestion test mineral release from the seeds was low overall. 26 12 | Composition data |
| Saponins (triterpenoid) | triterpenoid saponins | Seed coat More than 40 saponins identified, mainly from oleanolic acid and related compounds (review); amounts not given in the abstract | Bitter taste. In lab and animal work: vaccine adjuvant potential and anticancer activity in cells. Not shown in people eating quinoa. 9 | In vitro and animal |
| Carotenoids and vitamin E forms | pigments and tocochromanols | Seed Present in the seeds; amounts not given in the abstract (USDA lists vitamin E 0.63 mg per 100 g cooked and beta-carotene 3 micrograms) | Fat-soluble compounds whose release in a lab digestion test was low to medium. 12 26 | Composition data and in vitro |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Saponins and mineral release | Not specified | Saponins can form complexes with minerals and cholesterol in theory, but in an in vitro digestion of 12 quinoa genotypes bitter and non-bitter seeds did not differ in release of minerals, carotenoids or vitamin E forms. Lab model, not people. 12 | Laboratory research |
| Inflammation signals (IL-6, IL-1 beta, TNF-alpha) | Cytokines | Lower in cell studies and 8 of 14 animal studies after quinoa. Preclinical only. 13 | Animal and in vitro |
| Celiac-toxic protein parts | Prolamin epitopes recognised by celiac T cells | Most of 15 varieties had no measurable celiac-toxic parts; 2 varieties activated celiac T cells and biopsy responses in the lab. Lab and cell tests only. 18 | Laboratory research |
Absorption, metabolism and elimination
- Absorption
- Not found for quinoa nutrients in people. A lab digestion test found low mineral bioaccessibility and low to medium release of carotenoids and vitamin E forms.
- Distribution
- Not found.
- Metabolism
- Not found.
- Elimination
- Not found.
- Bioavailability
- Not established for quinoa nutrients in the sources read.
Isolated compounds versus whole extracts
The human trials used whole quinoa seed, quinoa flour or foods made with it (biscuits, bread). Saponin extracts and other isolated compounds are a separate lab topic; no human trial of them was read, and nothing here applies to extracts or supplements.
Nutritional composition
Nutrition from USDA FoodData Central (SR Legacy, April 2018 release; values read 2026-10-26 from a saved copy of the data feed). Cooked quinoa (FDC 168917), per 100 g: 120 kcal, 4.4 g protein, 1.92 g fat (0.231 g saturated), 21.3 g carbohydrate, 0.87 g sugars, 2.8 g fibre, about 71.6 g water, 17 mg calcium, 1.49 mg iron, 64 mg magnesium, 152 mg phosphorus, 172 mg potassium, 7 mg sodium, 1.09 mg zinc, 0.631 mg manganese, 0.192 mg copper, 42 micrograms folate (DFE), 0.107 mg thiamin; no vitamin B12, vitamin C or vitamin K are listed. One cup of cooked quinoa (185 g): about 222 kcal, 8.1 g protein, 5.2 g fibre, 118 mg magnesium, 1.17 mg manganese, 0.36 mg copper, 281 mg phosphorus, 78 micrograms folate, 2.0 mg zinc, 2.8 mg iron and 318 mg potassium (the per-100-g values multiplied by 1.85). Dry quinoa (FDC 168874), per 100 g: 368 kcal, 14.12 g protein, 7.0 g fibre, 4.57 mg iron and 197 mg magnesium; dry quinoa looks very different from cooked because cooked quinoa holds a lot of water, so compare cooked with cooked. Values vary with variety, growing place and cooking water. Flakes, flour, puffed and canned quinoa were not read.
1 high certainty1 mixed findings4 low certainty1 very low certainty1 not enough evidence
What was looked at
The 8 benefits and uses checked for Quinoa, each with how strong the evidence is. Tap one to open it.
- Blood sugar and insulinLow certainty
- Cholesterol and blood fatsLow certainty
- Body weight and body fatMixed findings
- Fibre, protein and minerals (nutrient content)High certainty
- Place in a gluten-free diet (celiac disease)Low certainty
- Gut bacteriaNot enough evidence
- Inflammation (lab and animal studies only)Very low certainty
- Long-term health (whole grains in general, observational)Low certainty
Lab markers tracked in the studies
Fasting blood glucoseHbA1c (3-month average blood sugar)LDL cholesterolTriglyceridesBody weightGut lining in celiac disease (villus height to crypt depth)Gut bacteria composition and diversity
What is Quinoa good for?
The main studied uses and how strong the human evidence is for each. Most results come from small, short trials.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
Blood sugar and insulin
Low certaintySmall trials give a hopeful but limited picture. A pooled analysis of 7 trials (258 adults, 15 to 50 g of quinoa a day) reported a beneficial effect on fasting glucose. A one-year trial in 207 adults with impaired glucose tolerance found better blood sugar measures with quinoa than with mixed whole grains or no change. A 4-week trial against rice and bulgur found no difference between groups.
3 studiesQuinoa seed as food, replacing part of the usual staple. The trials t…
Studies, doses and limits
What the trials found
Atefi 2024 pooled 7 randomised trials (258 adults, mean age 31 to 64, 15 to 50 g a day, 28 to 180 days) and found a non-linear dose-response with fasting glucose, the curve steepening near 25 g a day. Huang 2025 randomised 207 adults with impaired glucose tolerance to quinoa (about 100 g a day replacing about half the staple food), mixed whole grains or control for one year. Oztekin 2026 compared 40 g a day of quinoa, buckwheat, rice or bulgur for 4 weeks in 148 adults with overweight or obesity.
Results
Pooled trials favour quinoa for fasting glucose, and the one-year trial found longer time in range, lower 2-hour glucose, fasting insulin and insulin resistance, more people returning to normal glucose tolerance and fewer cases of diabetes than control or mixed grains (P < 0.05). The 4-week head-to-head trial found no significant differences between groups; fasting glucose fell only in men in the quinoa group.
Effect sizes as reported
No pooled glucose size is given in the abstract. One-year trial: differences reported as P < 0.05, no effect sizes in the abstract.
Why this rating
Randomised trials point the same way, but they are few and small, the pooled abstract gives no effect size, the biggest trial had no stated funding and one head-to-head trial found no difference.
Form and dose studied
Quinoa seed as food, replacing part of the usual staple. The trials tested food-sized amounts (15 to 100 g a day, trial detail, not advice).
Who was studied
Adults; one trial in people with impaired glucose tolerance (pre-diabetes); one in adults with overweight or obesity.
Limits
Few trials, mixed designs. The one-year trial replaced part of the staple food, so the result mixes adding quinoa with removing what it replaced. Not a treatment for diabetes.
Why researchers looked
Quinoa is a fibre and protein seed eaten in place of refined starches, so researchers ask whether it changes blood sugar.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Unknown
Not tested in these studies. Fibre, protein and slow digestion of the whole seed are the usual explanations.
A proposed mechanism does not show that the effect happens in people.
None specific. If you take medicine for blood sugar, ask your clinician before big diet changes.
Cholesterol and blood fats
Low certaintyPooled trials found small drops in triglycerides (about 7 mg/dl), total cholesterol (about 7 mg/dl) and LDL cholesterol (about 3 mg/dl). A crossover trial of quinoa biscuits in older adults found small drops in total and LDL cholesterol against wheat biscuits. The changes are small, and one 4-week trial found cholesterol rose in women.
3 studiesQuinoa seed and quinoa-flour products as food.
Studies, doses and limits
What the trials found
Karimian 2021 pooled 5 randomised trials (206 adults). Pourshahidi 2020 gave 40 healthy adults aged 50 to 75 either 15 g quinoa biscuits (60 g quinoa flour per 100 g) or matched wheat biscuits daily for 4 weeks in a crossover design. Oztekin 2026 gave 148 adults 40 g a day of quinoa, buckwheat, rice or bulgur for 4 weeks.
Results
Pooled: triglycerides -7.20 mg/dl, total cholesterol -6.86 mg/dl and LDL -3.08 mg/dl, all with confidence intervals that exclude zero. Biscuit trial: total cholesterol -0.30 mmol/L and LDL -0.25 mmol/L more than control (P < 0.05); triglycerides and HDL did not differ. Oztekin: no difference between groups; within the quinoa group total cholesterol fell in men but rose in women and HDL fell in women.
Effect sizes as reported
Triglycerides -7.20 mg/dl (95% CI -9.52 to -4.87); total cholesterol -6.86 mg/dl (-10.64 to -3.08); LDL -3.08 mg/dl (-5.13 to -1.03); biscuit trial LDL -0.25 mmol/L.
Why this rating
Randomised trials, but only about 5 small short trials, tiny changes, a product (biscuit) rather than cooked seed in one, and a null group comparison in another.
Form and dose studied
Quinoa seed and quinoa-flour products as food.
Who was studied
Adults, including healthy older adults and adults with overweight or obesity.
Limits
Short trials (4 weeks in the biscuit and head-to-head studies). Effects of a few mg/dl are very small. Heart attacks and strokes were not measured.
Why researchers looked
Quinoa seed has fibre and unsaturated fats, so researchers test whether eating it changes blood fats.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Unknown
Not tested in these studies.
A proposed mechanism does not show that the effect happens in people.
None specific.
Body weight and body fat
Mixed findingsResults are mixed. One pooled analysis of 5 trials found about 1.3 kg lower weight and a smaller waist. Another pooled analysis of 7 trials found no significant change in weight or BMI. A 148-adult trial found no difference from rice or bulgur after 4 weeks.
4 studiesQuinoa seed and quinoa-flour products as food.
Studies, doses and limits
What the trials found
Karimian 2021 pooled 5 trials (206 adults). Atefi 2024 pooled 7 trials (258 adults, 15 to 50 g a day). Pourshahidi 2020 (40 older adults, 15 g quinoa biscuits a day for 4 weeks) measured weight. Oztekin 2026 (148 adults, 40 g a day for 4 weeks) compared quinoa with rice and bulgur.
Results
Karimian: weight -1.26 kg, waist -1.15 cm, fat mass -0.59%. Atefi: BMI -0.25 and weight -0.54 kg versus placebo, not significant. Biscuit trial: weight -0.61 kg versus wheat biscuits. Head-to-head trial: no significant difference between quinoa, buckwheat, rice and bulgur; fat mass fell within the quinoa group.
Effect sizes as reported
Weight -1.26 kg (95% CI -2.35 to -0.18, Karimian); weight -0.54 kg (95% CI -3.05 to 1.97, not significant, Atefi).
Why this rating
Two pooled analyses of overlapping small trials disagree, and the one head-to-head trial found no difference between groups.
Form and dose studied
Quinoa seed and quinoa-flour products as food.
Who was studied
Adults, with and without overweight.
Limits
Small, short trials. Even the positive results are about 1 kg.
Why researchers looked
Quinoa has fibre and protein that may help fullness, so researchers ask whether it changes weight.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Unknown
Not tested in these studies.
A proposed mechanism does not show that the effect happens in people.
None specific.
Fibre, protein and minerals (nutrient content)
High certaintyCooked quinoa has 2.8 g of fibre and 4.4 g of protein per 100 g, and one cup (185 g) has about 5.2 g of fibre, 8.1 g of protein, 118 mg of magnesium and 1.17 mg of manganese, by USDA data. This is a nutrient fact, not a trial of quinoa.
2 studiesCooked quinoa as food.
Studies, doses and limits
What the trials found
USDA FoodData Central lists boiled quinoa (FDC 168917), per 100 g: 120 kcal, 4.4 g protein, 1.92 g fat, 21.3 g carbohydrate, 2.8 g fibre, 64 mg magnesium, 0.631 mg manganese, 0.192 mg copper, 152 mg phosphorus, 42 micrograms folate (DFE), 1.09 mg zinc, 1.49 mg iron, 172 mg potassium. It lists no vitamin B12, vitamin C or vitamin K.
Results
Cooked quinoa is a source of fibre, protein, magnesium, manganese, copper, phosphorus, folate and zinc. No trial was read showing that eating quinoa corrects a deficiency.
Effect sizes as reported
Per 1 cup cooked (185 g): about 222 kcal, 8.1 g protein, 5.2 g fibre, 118 mg magnesium, 1.17 mg manganese, 281 mg phosphorus, 78 micrograms folate, 2.8 mg iron.
Why this rating
High that cooked quinoa contains these nutrients (USDA data). Not tested as a treatment for any deficiency.
Form and dose studied
Cooked quinoa as food.
Who was studied
General adult diet.
Limits
A nutrient fact. Values vary with variety, growing place and cooking water. A 2026 lab test found low release of minerals during digestion (see Science), so the amount the body takes up is not the amount in the table.
Why researchers looked
Quinoa is eaten for its fibre, protein and minerals, so people ask what a serving supplies.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Unknown
Fibre adds bulk and slows digestion. Stated as general nutrition, not tested here.
A proposed mechanism does not show that the effect happens in people.
None specific.
Place in a gluten-free diet (celiac disease)
Low certaintyQuinoa is naturally gluten-free, and celiac disease groups list it as safe. In a small 6-week study of 19 treated celiac patients, 50 g a day was well tolerated. A lab test found that 2 of 15 quinoa varieties had proteins that stirred up immune cells from celiac patients, so labelled, tested products are still advised.
4 studiesQuinoa seed as food within a gluten-free diet.
Studies, doses and limits
What the trials found
The Celiac Disease Foundation lists quinoa among naturally gluten-free foods and NIDDK lists quinoa flour as safe. Zevallos 2014 gave 19 treated celiac patients 50 g of quinoa a day for 6 weeks. Zevallos 2012 tested 15 quinoa varieties in the lab.
Results
In the small study gut measures stayed normal, villus-to-crypt ratio moved from 2.8:1 to 3:1 and the authors concluded quinoa was well tolerated and did not make the condition worse. In the lab study, 4 varieties had measurable celiac-toxic parts, all below the maximum allowed for a gluten-free food, but 2 varieties (Ayacuchana and Pasankalla) triggered T cells and gut-biopsy responses comparable with gliadin.
Effect sizes as reported
Villus:crypt 2.8:1 to 3:1; intra-epithelial lymphocytes 30.3 to 29.7 per 100 enterocytes (19 patients, 6 weeks).
Why this rating
Agency guidance supports it, but the human evidence is one small uncontrolled 6-week study and the lab study found two varieties of concern.
Form and dose studied
Quinoa seed as food within a gluten-free diet.
Who was studied
Adults with treated celiac disease.
Limits
Short, small, no control group mentioned. The lab varieties are not the usual ones sold in shops. Cross-contact with gluten grains is the larger everyday risk (see Safety).
Why researchers looked
People who cannot eat gluten look for grains that are safe, and quinoa is a common choice.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Laboratory research
Quinoa has little of the prolamin protein that triggers celiac disease, but a few varieties carry some celiac-toxic parts (lab test).
A proposed mechanism does not show that the effect happens in people.
Celiac disease needs medical care. Ask your clinician or dietitian, and see the Safety tab on cross-contact.
Gut bacteria
Not enough evidenceIn 28 men who ate a roll with 20 g of quinoa flour a day for 4 weeks, gut bacteria did not change compared with a wheat-only roll. This small amount may simply have been too little to show an effect.
1 studiesQuinoa flour baked into bread rolls.
Studies, doses and limits
What the trials found
Li 2022 was a 4-week crossover trial in 28 adult men comparing a wheat roll with 20 g of whole-grain quinoa flour against a wheat-only roll, with stool sequencing before and after.
Results
No changes at phylum or genus level, and no change in diversity, in either period. The authors say larger amounts or longer periods are needed to test a dose-response.
Effect sizes as reported
No significant change (all p > 0.05).
Why this rating
One small trial, one small amount, men only, no effect found.
Form and dose studied
Quinoa flour baked into bread rolls.
Who was studied
28 adult men.
Limits
A null result at 20 g a day does not say what larger amounts do. Whole cooked quinoa was not tested.
Why researchers looked
Quinoa has fibre that gut bacteria can use, so researchers ask whether it shifts the gut microbiome.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Unknown
Not established. The trial found no change.
A proposed mechanism does not show that the effect happens in people.
None specific.
Inflammation (lab and animal studies only)
Very low certaintyA review of 20 animal and cell studies found that inflammation signals fell in the cell studies and in 8 of 14 animal studies. The authors call quinoa favourable but not yet a confirmed agent. No human trial was read.
1 studiesQuinoa in animal and cell experiments (forms vary).
Studies, doses and limits
What the trials found
Malek Mahdavi 2023 reviewed 20 animal and in vitro investigations up to July 2022.
Results
IL-6, IL-1 beta and TNF-alpha fell in the cell studies and in 8 of 14 animal studies. This does not show anything about people eating quinoa.
Why this rating
Animal and cell work only; no human data.
Form and dose studied
Quinoa in animal and cell experiments (forms vary).
Who was studied
Animals and cells, not people.
Limits
In 6 of 14 animal studies the signals did not clearly fall. Not evidence for people.
Why researchers looked
Quinoa contains plant compounds, so lab researchers test whether it calms inflammation signals.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism In vitro and animal
Lower IL-6, IL-1 beta and TNF-alpha signals in cells and animals.
A proposed mechanism does not show that the effect happens in people.
None specific.
Long-term health (whole grains in general, observational)
Low certaintyIn studies that follow people over time, those who ate more whole grains had less heart disease and fewer deaths. Quinoa is counted with the whole grains because its structure is similar, but it is not named in this analysis, so this is about whole grains in general.
2 studiesWhole grains as food (mostly cereals).
Studies, doses and limits
What the trials found
Aune 2016 pooled 45 prospective studies of whole grain intake. Quinoa is not named in the abstract. Two trial abstracts say quinoa is included in the whole-grain category because of its structure.
Results
Per 90 g a day more whole grain: coronary heart disease RR 0.81, cardiovascular disease RR 0.78, death from any cause RR 0.83, cancer death RR 0.85, stroke RR 0.88 (not significant).
Effect sizes as reported
CHD RR 0.81 (95% CI 0.75 to 0.87); CVD RR 0.78 (0.73 to 0.85); all-cause death RR 0.83 (0.77 to 0.90).
Why this rating
Observational only and not quinoa-specific.
Form and dose studied
Whole grains as food (mostly cereals).
Who was studied
Adults in cohort studies.
Limits
People who eat more whole grains may differ in other ways (diet, activity). Quinoa was not analysed on its own.
Why researchers looked
Large population studies ask whether people who eat more whole grains get heart disease less often.
Traditional use
Quinoa is cooked and eaten like a grain, for example as a side dish, in salads or as porridge. Long use as food is not proof that it treats any condition.
Proposed mechanism Unknown
Not established. The studies are observational.
A proposed mechanism does not show that the effect happens in people.
None specific.
Connections to the rest of health
How Quinoa connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Blood Sugar Balance | Low certainty | Blood sugar and insulin: Small trials give a hopeful but limited picture. A pooled analysis of 7 trials (258 adults, 15 to 50 g of quinoa a day) reported a beneficial effect on fasting glucose. A one-year trial in 207 adults with impaired glucose tolerance found better blood sugar measures with quinoa than with mixed whole grains or no change. A 4-week trial against rice and bulgur found no difference between groups. | 2 7 14 | |
| Cholesterol Balance | Low certainty | Cholesterol and blood fats: Pooled trials found small drops in triglycerides (about 7 mg/dl), total cholesterol (about 7 mg/dl) and LDL cholesterol (about 3 mg/dl). A crossover trial of quinoa biscuits in older adults found small drops in total and LDL cholesterol against wheat biscuits. The changes are small, and one 4-week trial found cholesterol rose in women. | 8 15 14 | |
| Heart Health | Low certainty | Cholesterol and blood fats: Pooled trials found small drops in triglycerides (about 7 mg/dl), total cholesterol (about 7 mg/dl) and LDL cholesterol (about 3 mg/dl). A crossover trial of quinoa biscuits in older adults found small drops in total and LDL cholesterol against wheat biscuits. The changes are small, and one 4-week trial found cholesterol rose in women. | 8 15 14 | |
| Healthy Weight | Mixed findings | Body weight and body fat: Results are mixed. One pooled analysis of 5 trials found about 1.3 kg lower weight and a smaller waist. Another pooled analysis of 7 trials found no significant change in weight or BMI. A 148-adult trial found no difference from rice or bulgur after 4 weeks. | 8 2 15 14 | |
| Digestive Support | Demonstrated clinical effect | High certainty | Fibre, protein and minerals (nutrient content): Cooked quinoa has 2.8 g of fibre and 4.4 g of protein per 100 g, and one cup (185 g) has about 5.2 g of fibre, 8.1 g of protein, 118 mg of magnesium and 1.17 mg of manganese, by USDA data. This is a nutrient fact, not a trial of quinoa. | 26 12 |
| Digestive Support | Low certainty | Place in a gluten-free diet (celiac disease): Quinoa is naturally gluten-free, and celiac disease groups list it as safe. In a small 6-week study of 19 treated celiac patients, 50 g a day was well tolerated. A lab test found that 2 of 15 quinoa varieties had proteins that stirred up immune cells from celiac patients, so labelled, tested products are still advised. Gut bacteria: In 28 men who ate a roll with 20 g of quinoa flour a day for 4 weeks, gut bacteria did not change compared with a wheat-only roll. This small amount may simply have been too little to show an effect. | 20 24 19 18 11 | |
| Microbiome Balance | Not enough evidence | Gut bacteria: In 28 men who ate a roll with 20 g of quinoa flour a day for 4 weeks, gut bacteria did not change compared with a wheat-only roll. This small amount may simply have been too little to show an effect. | 11 | |
| Inflammation Balance | Very low certainty | Inflammation (lab and animal studies only): A review of 20 animal and cell studies found that inflammation signals fell in the cell studies and in 8 of 14 animal studies. The authors call quinoa favourable but not yet a confirmed agent. No human trial was read. | 13 | |
| Heart Health | Low certainty | Long-term health (whole grains in general, observational): In studies that follow people over time, those who ate more whole grains had less heart disease and fewer deaths. Quinoa is counted with the whole grains because its structure is similar, but it is not named in this analysis, so this is about whole grains in general. | 3 11 | |
| Healthy Aging | Low certainty | Long-term health (whole grains in general, observational): In studies that follow people over time, those who ate more whole grains had less heart disease and fewer deaths. Quinoa is counted with the whole grains because its structure is similar, but it is not named in this analysis, so this is about whole grains in general. | 3 11 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Endocrine System | Biological association | Low certainty | Studied for: Blood sugar and insulin | 2 7 14 |
| Metabolism Weight | Biological association | Low certainty | Studied for: Blood sugar and insulin Studied for: Body weight and body fat | 2 7 14 8 15 |
| Cardiovascular System | Biological association | Low certainty | Studied for: Cholesterol and blood fats Studied for: Long-term health (whole grains in general, observational) | 8 15 14 3 11 |
| Digestive System | Biological association | High certainty | Studied for: Fibre, protein and minerals (nutrient content) Studied for: Place in a gluten-free diet (celiac disease) | 26 12 20 24 19 18 11 |
| Immune System | Biological association | Very low certainty | Studied for: Inflammation (lab and animal studies only) | 13 |
E. Health conditions
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Celiac disease | Documented risk | Naturally gluten-free and listed as safe, but cross-contact with gluten grains can occur; choose tested, labelled products. Preparation or compound: Quinoa seed and flour |
20 24 21 | |
| Food allergy | Adverse effect or risk | Documented risk | Case reports of quinoa allergy including anaphylaxis; frequency unknown. Preparation or compound: Quinoa protein |
1 6 4 10 |
| Impaired glucose tolerance | Limited | One one-year trial reported better blood sugar measures with quinoa than with mixed grains or no change; it needs repeating. Preparation or compound: Quinoa seed as food |
7 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Fasting blood glucose | Biological association | Low certainty | Measured in trials: lowered (pooled analysis); mixed. A lab change is not the same as a health benefit. | 2 14 |
| HbA1c (3-month average blood sugar) | Biological association | Low certainty | Measured in trials: improved versus control (one trial). A lab change is not the same as a health benefit. | 7 |
| LDL cholesterol | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 8 15 |
| Triglycerides | Biological association | Low certainty | Measured in trials: lowered (pooled analysis); no difference in one trial. A lab change is not the same as a health benefit. | 8 15 |
| Body weight | Biological association | Mixed findings | Measured in trials: mixed. A lab change is not the same as a health benefit. | 8 2 |
| Gut lining in celiac disease (villus height to crypt depth) | Biological association | Low certainty | Measured in trials: moved from 2.8:1 to 3:1 (no control group). A lab change is not the same as a health benefit. | 19 |
| Gut bacteria composition and diversity | Biological association | Not enough evidence | Measured in trials: no change. A lab change is not the same as a health benefit. | 11 |
K. Biological pathways
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Fibre | Preliminary mechanism | Composition data | Quinoa is a source of fibre by USDA data. | 26 |
| Magnesium | Preliminary mechanism | Composition data | Cooked quinoa has 64 mg magnesium per 100 g by USDA data. | 26 |
| Manganese | Preliminary mechanism | Composition data | Cooked quinoa has 0.631 mg manganese per 100 g by USDA data. | 26 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Dietary fibre | Biological association | Composition data | Provides fibre in the diet. Not tested here as a treatment. Preparation or compound: Seed |
26 25 |
| Protein | Biological association | Composition data | A review abstract describes a balance of essential amino acids; this was not checked against amino acid data. Preparation or compound: Seed |
26 5 |
| Minerals (magnesium, manganese, copper, phosphorus) | Biological association | Composition data | Nutrients the body needs. In a lab digestion test mineral release from the seeds was low overall. Preparation or compound: Seed |
26 12 |
| Saponins (triterpenoid) | Biological association | In vitro and animal | Bitter taste. In lab and animal work: vaccine adjuvant potential and anticancer activity in cells. Not shown in people eating quinoa. Preparation or compound: Seed coat |
9 |
| Carotenoids and vitamin E forms | Biological association | Composition data and in vitro | Fat-soluble compounds whose release in a lab digestion test was low to medium. Preparation or compound: Seed |
12 26 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).
Evidence at a glance: what changed in 2 lab markers
Tap a number to show only those markers. Counts are markers, not people.
The evidence
The research centre for Quinoa. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing quinoa summary, re-checked nutrition against USDA FoodData Central data, re-read the Celiac Disease Foundation, NIDDK, FDA and MedlinePlus pages and re-read PubMed abstracts for reviews, trials and allergy reports. Only abstracts (or titles, for four case reports) were read for studies. Items we could not verify are flagged in the research gaps.
Study library: every study we checked 26
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Astier 2009 First case report of anaphylaxis to quinoa, a novel food in France. Allergy · PMID 19220209 · DOI |
Case report |
1 One reported patient |
Quinoa eaten as food Quinoa as food |
The title reports a case of anaphylaxis (a severe allergic reaction) to quinoa. The record has no abstract, so no further detail was read. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Allergic reaction to quinoa Limitations: Title only; no abstract was available. A single case report cannot show how common quinoa allergy is. Funding and conflicts: Not stated. Read: title-only (no abstract) |
| Atefi 2024 Does Quinoa (Chenopodium quinoa) Consumption Improve Blood Glucose, Body Weight and Body Mass Index? A Systematic Review and Dose-Response Meta-Analysis of Clinical Trials. Curr Med Chem · PMID 36847233 · DOI |
Systematic review meta analysis |
258 258 adults (mean ages 31 to 64) in 7 randomised trials |
Quinoa seed as food (the authors call it 'quinoa seed supplementation') Quinoa seed or flour as food 15 to 50 g of quinoa a day (trial detail, not advice) 28 to 180 days · vs Placebo or control |
A dose-response analysis found a non-linear link between quinoa intake and fasting glucose, with the curve getting steeper near 25 g a day. The authors concluded quinoa had beneficial effects on blood glucose and ask for more studies. Compared with placebo, quinoa did not significantly change BMI or body weight. BMI MD -0.25; body weight MD -0.54 kg (both not significant). The abstract gives no pooled number for fasting glucose. (BMI 95% CI -0.98 to 0.47; body weight 95% CI -3.05 to 1.97) Methods, limits and fundingOutcomes: Fasting blood glucose (main), body weight, body mass index Limitations: Only 7 small trials. No pooled glucose size is given in the abstract. Search ended November 2022. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Aune 2016 Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ · PMID 27301975 · DOI |
Systematic review meta analysis |
45 prospective cohort studies (64 publications) of whole grain intake | Whole grains in general (quinoa is not named in the abstract) Whole grains in general Per 90 g a day increase in whole grains (analysis unit, not advice) Cohort follow-up varied · vs Lower intake |
Higher whole grain intake went with lower risk of coronary heart disease, cardiovascular disease, cancer death and death from any cause. There was no clear link with stroke. Refined grains and white rice showed little association. Per 90 g/day: coronary heart disease RR 0.81; cardiovascular disease RR 0.78; stroke RR 0.88 (not significant); cancer death RR 0.85; death from any cause RR 0.83 (CHD 0.75 to 0.87; CVD 0.73 to 0.85; stroke 0.75 to 1.03; cancer death 0.80 to 0.91; all-cause death 0.77 to 0.90) Methods, limits and fundingOutcomes: Cardiovascular disease, cancer, all-cause and cause-specific deaths Limitations: Observational, so it cannot prove cause: people who eat more whole grains may differ in other ways. Quinoa is not named, so this is whole grains in general, mostly wheat, oats, rice and similar cereals. Funding and conflicts: The authors declare no support from any organisation for the submitted work and no financial relationships that might have an interest in it. Read: abstract |
| Cuervo-Pardo 2015 Anaphylaxis after home-made quinoa dinner: hold the mustard. BMJ Case Rep · PMID 25733093 · DOI |
Case report |
1 One reported patient |
A home-made quinoa dinner A quinoa meal |
The title reports anaphylaxis after a home-made quinoa dinner and suggests mustard may have been involved. The record has no abstract, so no further detail was read. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Anaphylaxis after a quinoa meal Limitations: Title only; no abstract was available. The title points to a possible other trigger (mustard), so it is not clear quinoa itself was the cause. Funding and conflicts: Not stated. Read: title-only (no abstract) |
| Filho 2017 Quinoa: Nutritional, functional, and antinutritional aspects. Crit Rev Food Sci Nutr · PMID 26114306 · DOI |
Narrative review n/a |
Narrative review of quinoa composition | Quinoa as a food plant Quinoa as a food plant |
The review describes quinoa as originally from the Andean regions, rich in proteins, lipids, fibre, vitamins and minerals with a balance of essential amino acids, and gluten-free so it can be used by celiac patients. It says more studies are needed to learn the antinutritional effects of this pseudo-cereal. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Composition and antinutritional factors of quinoa Limitations: Narrative review; the abstract gives no numbers. It places quinoa in the plant family Chenopodiaceae, an older grouping. Funding and conflicts: Not stated. Read: abstract |
| Hong 2013 Anaphylaxis to quinoa. Ann Allergy Asthma Immunol · PMID 23244665 · DOI |
Case report |
1 One reported patient |
Quinoa eaten as food Quinoa as food |
The title reports anaphylaxis to quinoa (a case report or letter). The record has no abstract, so no further detail was read. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Allergic reaction to quinoa Limitations: Title only; no abstract was available. A single case report cannot show how common quinoa allergy is. Funding and conflicts: Not stated. Read: title-only (no abstract) |
| Huang 2025 Quinoa is more effective than other whole grains in the management of impaired glucose tolerance: a randomized controlled trial. Food Funct · PMID 39784492 · DOI |
Controlled trial |
207 207 adults with impaired glucose tolerance (a pre-diabetes state) |
Quinoa, about 100 g a day replacing about half of the daily staple food Quinoa seed or flour as food 100 g a day (trial detail, not advice) 1 year · vs Mixed whole grains (100 g a day) or a control group |
The quinoa group had longer time in range, more people returning to normal glucose tolerance, lower 2-hour glucose, fasting insulin, HOMA-IR and 14-day mean glucose, and fewer cases of diabetes than the multigrain and control groups (all P < 0.05). HbA1c improved in both the quinoa and multigrain groups compared with control. The authors call quinoa more effective than a multiple whole-grain diet for impaired glucose tolerance. Differences reported as P < 0.05; the abstract gives no effect sizes. (Not given in the abstract) Methods, limits and fundingOutcomes: Blood sugar measures (time in range, 2-hour glucose, 14-day mean glucose), fasting insulin, insulin resistance (HOMA-IR), HbA1c, conversion to normal glucose tolerance, development of diabetes Limitations: One trial from one centre. The abstract gives no effect sizes, no blinding statement and no funding. Quinoa replaced part of the staple food, so the comparison mixes quinoa with what it replaced. Funding and conflicts: Funding and conflicts are not stated in the abstract. Read: abstract |
| Karimian 2021 The effects of quinoa seed supplementation on cardiovascular risk factors: A systematic review and meta-analysis of controlled clinical trials. Phytother Res · PMID 33037704 · DOI |
Systematic review meta analysis |
206 206 adults in 5 randomised trials |
Quinoa seed as food (the authors call it 'quinoa seed supplementation') Quinoa seed or flour as food Not given in the abstract Not given in the abstract · vs Controls |
Quinoa lowered body weight, waist circumference, fat mass, insulin, triglycerides, total cholesterol and LDL cholesterol by small amounts. Other markers did not change significantly. Body weight -1.26 kg; waist -1.15 cm; fat mass -0.59%; triglycerides -7.20 mg/dl; total cholesterol -6.86 mg/dl; LDL -3.08 mg/dl (Weight -2.35 to -0.18; waist -2.08 to -0.21; fat mass -1.14 to -0.03; triglycerides -9.52 to -4.87; total cholesterol -10.64 to -3.08; LDL -5.13 to -1.03) Methods, limits and fundingOutcomes: Body weight, waist, fat mass, insulin, triglycerides, total and LDL cholesterol and other cardiovascular risk markers Limitations: Only 5 small trials. The changes are small. The abstract lists the insulin result as -0.86 pmol/L with a confidence interval of -13.38 to -1.59, which does not contain the estimate, so the insulin number is not quoted on this page. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Karydogianni 2026 Quinoa (Chenopodium quinoa Willd.) Saponins and Their Pharmaceutical Potential: A Review. Int J Mol Sci · PMID 42589336 · DOI |
Narrative review in-vitro-and-animal |
Review of the literature on quinoa saponins | Saponins extracted from quinoa seeds (not the food) Saponins (extract) from quinoa seed |
Quinoa seeds are rich in proteins, lipids, carbohydrates, minerals and saponins. Saponins taste bitter and are typically removed before eating. They have been called antinutritional, but are studied for drug uses: promise as vaccine adjuvants and anticancer activity in breast and colon cancer cells. At high concentrations saponins can burst red blood cells in general, and in living animals no adverse effects were recorded below 50 mg/kg of body weight per day. More than 40 saponins have been identified, mainly from oleanolic acid and related compounds. No adverse effects recorded in vivo below 50 mg/kg body weight a day (Not applicable) Methods, limits and fundingOutcomes: What saponins are, how they are extracted, and their lab and animal effects Limitations: A review of mostly lab work on extracts, not the food. The species for the in vivo statement is not given in the abstract. Funding and conflicts: The authors declare no conflicts of interest. Read: abstract |
| Leonhardt 2026 [Superfood sensitization-two cases of a quinoa allergy]. Dermatologie (Heidelb) · PMID 42811216 · DOI |
Case report |
2 Two reported patients (German-language article) |
Quinoa eaten as food Quinoa as food |
The title reports two cases of quinoa allergy. The record has no abstract, so no further detail was read. The article is part of a supplement sponsored by LEO Pharma GmbH. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Quinoa allergy (sensitisation) Limitations: Title only; no abstract was available. Two cases cannot show how common quinoa allergy is. Funding and conflicts: Part of a supplement sponsored by LEO Pharma GmbH, per the record. Read: title-only (no abstract) |
| Li 2022 Impact of Daily Consumption of Whole-Grain Quinoa-Enriched Bread on Gut Microbiome in Males. Nutrients · PMID 36432574 · DOI |
Controlled trial |
28 28 adult men |
Wheat bread roll with 20 g quinoa flour (whole-grain quinoa), compared with a wheat-only roll Quinoa seed or flour as food 20 g of quinoa flour a day (trial detail, not advice) 4 weeks, crossover with a 4-week washout · vs Wheat-only bread roll |
No changes in gut bacteria at phylum or genus level from the start to week 4 in either the quinoa or the control period. Diversity did not change. The authors say substituting 20 g of refined wheat flour with quinoa flour did not significantly change the gut microbiome, and that higher amounts or longer periods need testing. No significant change (all p > 0.05) (Not applicable) Methods, limits and fundingOutcomes: Gut bacteria in stool (16S rRNA sequencing): groups at phylum and genus level, diversity Limitations: Small, short, all men, a small amount of quinoa. A null result at this amount does not say what larger amounts do. Funding and conflicts: The authors declare no conflict of interest. Funding is not stated in the abstract. Read: abstract |
| Lindenmayer 2026 Saponins Do Not Impede the Bioaccessibility of Minerals and Fat-Soluble Vitamins from Different Quinoa Genotypes. J Agric Food Chem · PMID 42030452 · DOI |
Laboratory research in-vitro |
Seeds of 12 quinoa genotypes (6 bitter, 6 non-bitter) in a lab digestion model | Raw quinoa seeds in a test-tube digestion model Quinoa seeds in a lab digestion model · vs Bitter versus non-bitter genotypes |
Bitter and non-bitter quinoa did not differ in stability, solubility, bioaccessibility or micelle properties of these compounds. Mineral bioaccessibility was low, and that of the fat-soluble compounds was low to medium. The authors conclude saponins do not appear to impair release of minerals, carotenoids and vitamin E forms. Not applicable (qualitative) (Not applicable) Methods, limits and fundingOutcomes: How much of the minerals, carotenoids and vitamin E forms were released (bioaccessible) from the seeds Limitations: A lab digestion model, not people. Uncooked seed. The abstract gives no numbers. Funding and conflicts: Funding and conflicts are not stated in the abstract. Read: abstract |
| Malek Mahdavi 2023 Effects of Quinoa (Chenopodium quinoa) on inflammatory mediators: a systematic review of preclinical studies. Inflammopharmacology · PMID 36331709 · DOI |
Systematic review meta analysis animal-and-in-vitro |
20 animal and in vitro (cell) investigations; no human trials | Quinoa given to animals or applied in cell tests Quinoa (form varies) in animal and cell studies · vs Controls |
In the cell studies and in 8 of 14 animal studies, IL-6, IL-1 beta and TNF-alpha levels fell clearly after quinoa. The authors call quinoa favourable but not yet a confirmed agent for easing whole-body inflammation in inflammatory diseases. Not applicable (qualitative summary) (Not applicable) Methods, limits and fundingOutcomes: IL-6, IL-1 beta and TNF-alpha (inflammation signals) Limitations: Lab and animal work only. In 6 of 14 animal studies the markers did not clearly fall. Not evidence for people. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Oztekin 2026 Comparative Effects of Quinoa, Buckwheat, Bulgur, and Rice on Cardiometabolic Health in Adults with Overweight or Obesity: A Randomized Controlled Study. Metabolites · PMID 42783753 · DOI |
Controlled trial |
148 148 adults aged 25 to 45 with overweight or obesity |
Quinoa, buckwheat, rice or bulgur as food Quinoa seed or flour as food 40 g a day (trial detail, not advice) 4 weeks · vs Rice or bulgur (and buckwheat as the other pseudocereal) |
The changes did not differ significantly between the four groups. Within the quinoa group, fat mass fell and fasting glucose fell only in men. Total cholesterol fell in men but rose in women after quinoa, and HDL cholesterol fell in women. The authors say sex-specific differences may occur and that more studies are needed. No significant differences between groups; within-group changes only (P < 0.05 for those reported). (Not given in the abstract) Methods, limits and fundingOutcomes: Body measures, blood pressure, blood sugar, insulin, blood fats Limitations: Short (4 weeks). Within-group changes without a difference between groups are weak evidence. Results split by sex. Funding and conflicts: The authors declare no conflicts of interest. Funding is not stated in the abstract. Read: abstract |
| Pourshahidi 2020 Modest improvement in CVD risk markers in older adults following quinoa (Chenopodium quinoa Willd.) consumption: a randomized-controlled crossover study with a novel food product. Eur J Nutr · PMID 31919583 · DOI |
Controlled trial |
40 40 healthy adults aged 50 to 75 (82.5% had cholesterol above 5 mmol/L at the start) |
Quinoa biscuits made with 60 g quinoa flour per 100 g Quinoa seed or flour as food 15 g of biscuit a day (trial detail, not advice) 4 weeks, crossover with a 6-week washout · vs Matched wheat-flour biscuits |
Total and LDL cholesterol, the total-to-HDL ratio, weight and BMI fell more after quinoa biscuits than after wheat biscuits (all P < 0.05). Triglycerides, HDL cholesterol and CRP did not differ significantly. Total cholesterol -0.30 mmol/L (SD 0.58); LDL -0.25 mmol/L (SD 0.38); weight -0.61 kg (SD 0.89); BMI -0.22 kg/m2 (Not given in the abstract (mean and SD only)) Methods, limits and fundingOutcomes: Total and LDL cholesterol, weight, BMI, triglycerides, HDL, CRP Limitations: Small trial; a quinoa-flour biscuit, not whole cooked seed. Short. Funding is not stated in the abstract. Funding and conflicts: Funding and conflicts are not stated in the abstract. Read: abstract |
| Präger 2023 Food allergy - New risks through vegan diet? Overview of new allergen sources and current data on the potential risk of anaphylaxis. J Dtsch Dermatol Ges · PMID 37723909 · DOI |
Narrative review |
Review of allergens in plant-based diets | Plant foods including pseudo-grains (quinoa, buckwheat) Plant foods in general |
The review says vegan menus are supplemented with pulses, nuts, seeds and pseudo-grains (quinoa, buckwheat), and that the main anaphylaxis allergens in adults are mostly plant foods, especially pulses and nuts. It singles out soy and pea protein, not quinoa, for detail. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Allergen sources in vegan diets Limitations: Quinoa is named only in passing in the abstract. Funding and conflicts: Not stated. Read: abstract |
| Treudler 2024 Emerging and Novel Elicitors of Anaphylaxis: Collegium Internationale Allergologicum Update 2024. Int Arch Allergy Immunol · PMID 38527454 · DOI |
Narrative review |
Review of newer causes of anaphylaxis | Foods in general Foods in general |
The review lists pseudograins (buckwheat and quinoa) among food allergens on the rise, alongside pulses, seeds, nuts, fruits and microalgae. It does not give numbers for quinoa in the abstract. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Which foods are on the rise as causes of anaphylaxis Limitations: A short narrative review; no quinoa numbers in the abstract. Funding and conflicts: Not stated. Read: abstract |
| Zevallos 2012 Variable activation of immune response by quinoa (Chenopodium quinoa Willd.) prolamins in celiac disease. Am J Clin Nutr · PMID 22760575 · DOI |
Laboratory research in-vitro |
15 quinoa varieties from the Andes, tested with immune cells and gut-biopsy samples from celiac patients | Quinoa seed proteins in the lab Quinoa seed proteins in the lab · vs Gliadin (the wheat protein that triggers celiac disease) |
Four of 15 varieties had measurable celiac-toxic parts, all below the maximum allowed for a gluten-free food. Varieties Ayacuchana and Pasankalla stimulated T-cell lines and cytokine release from biopsy samples at levels comparable with gliadin. The authors conclude most varieties have no measurable celiac-toxic parts, but 2 could activate immune responses in some patients, and ask for in vivo studies. Qualitative (Not applicable) Methods, limits and fundingOutcomes: Celiac-toxic protein parts (epitopes) in quinoa and the immune response of celiac patients' cells Limitations: Lab and cell tests on tissue from patients, not people eating quinoa. Names of varieties are Andean types not necessarily sold in shops. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Zevallos 2014 Gastrointestinal effects of eating quinoa (Chenopodium quinoa Willd.) in celiac patients. Am J Gastroenterol · PMID 24445568 · DOI |
Clinical trial uncontrolled |
19 19 adults with celiac disease already treated with a gluten-free diet (gut biopsies in 10) |
Quinoa added to their usual gluten-free diet Quinoa seed or flour as food 50 g of quinoa a day (trial detail, not advice) 6 weeks · vs Before-and-after comparison; no separate control group is mentioned in the abstract |
Gut measures stayed normal. The villus-to-crypt ratio moved from 2.8:1 to 3:1, and intra-epithelial lymphocytes per 100 cells from 30.3 to 29.7. Blood tests stayed in normal ranges, with total cholesterol 4.6 to 4.3 mmol/L. The authors conclude quinoa was well tolerated and did not make the condition worse, and say longer studies are needed. Villus:crypt 2.8:1 to 3:1; intra-epithelial lymphocytes 30.3 to 29.7 per 100 enterocytes; total cholesterol 4.6 to 4.3 mmol/L (Not given in the abstract) Methods, limits and fundingOutcomes: Gut symptoms, blood tests, gut lining biopsy (villus height to crypt depth ratio, immune cells), cholesterol Limitations: Small, 6 weeks, no control group mentioned, only 10 people had biopsies. It shows short-term tolerance, not long-term safety. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| s-celiac-foundation Celiac Disease Foundation: Gluten-free foods · Source |
Patient organisation n/a |
Methods, limits and fundingRead: full-text | ||
| s-fda-gf FDA: Questions and Answers: Gluten-Free Food Labeling Final Rule · Source |
Regulator n/a |
Methods, limits and fundingRead: full-text | ||
| s-gbif-chenopodium-quinoa GBIF Backbone: Chenopodium quinoa Willd. (usageKey 3083935) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-medlineplus-foodallergy MedlinePlus: Food allergy · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-celiac NIDDK: Eating, diet, and nutrition for celiac disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-168874 USDA FoodData Central: Quinoa, uncooked (FDC 168874) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-168917 USDA FoodData Central: Quinoa, cooked (FDC 168917) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- No trial of quinoa measured heart attacks or strokes. The longest trial lasted one year and most lasted 4 weeks.
- The pooled analyses combine a few small trials of different forms (seed, flour, biscuits), and the pooled blood sugar abstract gives no effect size.
- How common quinoa allergy is was not found; the case reports were read by title only.
- Oxalate, purines (gout), FODMAP rating, heavy metals, pesticide residues, cooking and rinsing effects, and safety in pregnancy or for young children were not researched for quinoa.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Metabolic 5
Fasting blood glucose
Lowered (pooled analysis); mixed in trials
Blood sugar measured after not eating overnight.
Low certaintyResults and what it means
Why it was measured
A basic measure of blood sugar control.
Statistical vs. clinical meaning
A hopeful pooled signal without a stated size, and one null head-to-head trial.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 2 | Non-linear dose-response with fasting glucose (P for nonlinearity = 0.027), curve steeper near 25 g a day; the authors report a beneficial effect (no pooled size in the abstract) | 258 adults in 7 trials | Quinoa 15 to 50 g a day, 28 to 180 days |
| 14 | No significant difference between groups; fasting glucose fell only in men within the quinoa group | 148 adults with overweight or obesity | Quinoa 40 g a day for 4 weeks versus buckwheat, rice, bulgur |
HbA1c (3-month average blood sugar)
Improved versus control (one trial) in trials
A blood test that reflects average blood sugar over about three months.
Low certaintyResults and what it means
Why it was measured
Used to judge long-term blood sugar control.
Statistical vs. clinical meaning
One trial, abstract gives no numbers.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 7 | HbA1c improved in both the quinoa and the multigrain groups compared with control (P < 0.05); no sizes in the abstract | 207 adults with impaired glucose tolerance | Quinoa about 100 g a day for one year |
LDL cholesterol
Lowered in trials
The 'bad' cholesterol carried in the blood. Higher levels are linked to more heart disease.
Low certaintyResults and what it means
Why it was measured
The usual blood marker used in diet trials for heart risk.
Statistical vs. clinical meaning
Small changes in small, short trials.
Safety implication
None specific.
Triglycerides
Lowered (pooled analysis); no difference in one trial in trials
A type of fat in the blood.
Low certaintyResults and what it means
Why it was measured
High levels are linked to heart risk.
Statistical vs. clinical meaning
A small pooled drop; one trial found none.
Safety implication
None specific.
Body weight
Mixed results in trials
Weight in kilograms measured in a trial.
Mixed findingsResults and what it means
Why it was measured
A basic measure used in diet trials.
Statistical vs. clinical meaning
Two pooled analyses disagree on significance.
Safety implication
None specific.
Other 2
Gut lining in celiac disease (villus height to crypt depth)
Moved from 2.8:1 to 3:1 (no control group) in trials
A biopsy measure of how healthy the lining of the small bowel is; a higher ratio is healthier.
Low certaintyResults and what it means
Why it was measured
Used to see whether a food harms the gut in celiac disease.
Statistical vs. clinical meaning
One small uncontrolled study; shows short-term tolerance.
Safety implication
Celiac disease needs medical care.
| Study | Result | People | Product |
|---|---|---|---|
| 19 | Villus height to crypt depth 2.8:1 to 3:1; intra-epithelial lymphocytes 30.3 to 29.7 per 100 enterocytes; the authors report a positive trend and no worsening | 10 treated celiac patients with biopsies (19 in the study) | Quinoa 50 g a day for 6 weeks added to a gluten-free diet |
Gut bacteria composition and diversity
No change in trials
Which bacteria are in stool and how varied they are.
Not enough evidenceResults and what it means
Why it was measured
A way to see whether a food changes the gut environment.
Statistical vs. clinical meaning
One small trial with a small amount; no effect seen.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 11 | No change at phylum or genus level and no change in diversity (all p > 0.05) | 28 adult men | 20 g quinoa flour a day in a bread roll for 4 weeks versus a wheat-only roll |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 3
- Gluten-free, but check for cross-contact if you have celiac disease. Quinoa is naturally gluten-free, and the Celiac Disease Foundation and NIDDK both list it as safe. Both also warn that gluten can get into naturally gluten-free grains during growing, harvest, processing, storage and cooking. The Foundation says to buy grains tested to under 20 parts per million and not to buy from bulk bins. In the US, a food labelled gluten-free must have any unavoidable gluten below 20 ppm (FDA, content current as of 2022-06-30). In a lab study, 2 of 15 quinoa varieties had proteins that stirred up immune cells from celiac patients, so a small risk from the grain itself cannot be ruled out for every variety. Authoritative guidance 20 24 21 18 19
- Quinoa allergy is rare but real, and can be severe. Case reports describe anaphylaxis to quinoa, and two allergy reviews list quinoa among pseudograins that are becoming more frequent food allergens. Only titles of the case reports were available, and no frequency was found, so how common quinoa allergy is remains unknown. For trouble breathing or swelling of the face or throat after eating, call emergency services (MedlinePlus advises calling 911). Case report 1 6 4 10 17 16 23
- Saponins: the bitter coating. Quinoa seeds carry saponins, which taste bitter and are typically removed before the seed is eaten. A 2026 review calls them antinutritional in the older literature and reports that, in living animals, no adverse effects were recorded below 50 mg/kg of body weight a day; at high concentrations saponins can burst red blood cells in lab tests. This is about extracts, not the amount left in prepared quinoa, and no source read describes harm from eating prepared quinoa. Narrative review 9 5
Side effects 2
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Allergic reactions to quinoa, including anaphylaxis Single cases and a two-case report. They show it can happen, not how often. One title suggests another trigger (mustard) in one case. | Not established | can be severe (anaphylaxis) Not found | Case report 1 6 4 10 |
| Gut or other symptoms in celiac patients Small, short, no control group mentioned. Lab tests found 2 of 15 varieties could stir up celiac immune cells. | In 19 treated celiac patients eating 50 g of quinoa a day for 6 weeks, gut parameters were normal and the authors reported it was well tolerated. | none reported Not applicable | Clinical trial uncontrolled 19 |
Liver
No liver injury from eating quinoa was found in the sources read. A liver-safety source (such as LiverTox) was not searched for food.
How often. No frequency was found.
Monitoring. No agency monitoring advice was found.
This is a safety connection. It is not evidence that Quinoa supports liver health.
Medicines and supplements 2
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Medicines for diabetes prescription | Quinoa trials lowered blood sugar markers a little; a large change in diet could in theory add to the effect of blood sugar medicines. | No source read tied quinoa to a specific medicine interaction. This is a general caution, not a documented interaction. | Theoretical Not enough evidence 2 7 | Ask your clinician or pharmacist before making big diet changes if you take diabetes medicine. |
| Warfarin (blood thinner) prescription | Vitamin K affects clotting and warfarin works against it. USDA lists no vitamin K (0.0 micrograms per 100 g) in cooked quinoa. | No source read names quinoa as a concern for warfarin. Steady eating habits matter more than any one food. | None found Not enough evidence 26 | Ask your warfarin clinic about any big change in diet. Do not change medicine on your own. |
Who should check first 4
| Situation | Advice | Evidence |
|---|---|---|
| Known or suspected quinoa allergy | Avoid quinoa until an allergist has advised you. Allergic reactions to quinoa have been reported, including anaphylaxis. | Case report 1 6 |
| Celiac disease or gluten sensitivity | Quinoa itself is listed as gluten-free, but choose products labelled and tested gluten-free and avoid bulk bins. Ask your clinician or dietitian. | Authoritative guidance 20 24 21 |
| Kidney disease on a potassium or phosphorus limit | Cooked quinoa has 172 mg of potassium and 152 mg of phosphorus per 100 g by USDA. No quinoa-specific kidney source was read, so ask your kidney team or dietitian how it fits your limits. | None found 26 |
| Pregnancy, breastfeeding and young children | No quinoa-specific statement from an official body was read. Quinoa is an ordinary food, but ask your doctor, midwife or dietitian about your own diet. Choking risk and allergy for young children were not researched for quinoa. | None found |
Overdose, product quality and regulators
Summary. No toxicity from cooked quinoa as ordinary food was found in the sources read. Quinoa saponins are a bitter coating usually removed before eating; lab and animal work on saponin extracts is not the same as eating the food.
Animal. A 2026 review says no adverse effects were recorded in vivo below 50 mg/kg of body weight a day of saponins (species not given in the abstract); at high concentrations saponins can burst red blood cells in lab tests.
Human doses studied. Trials used quinoa seed or flour products in food-sized amounts (15 to 100 g a day, trial detail, not advice) for 4 weeks to one year. The abstracts do not report serious harms.
Overdose response. Not found.
Genotoxicity. Not researched.
Toxic or hazardous parts. The seed coat carries bitter saponins (usually removed before sale). Other parts of the plant were not covered.
Gluten cross-contact is the documented concern for people with celiac disease. Heavy metals, pesticide residues, mould and oxalate were not researched for quinoa.
Gluten cross-contact. NIDDK says cross-contact can occur when foods are grown, processed, stored, prepared or served. The Celiac Disease Foundation says some naturally gluten-free grains may contain gluten from harvesting and processing and advises tested products under 20 ppm and avoiding bulk bins. FDA says unavoidable gluten in a gluten-free labelled food must be below 20 ppm. 20 24 21
Saponin residue. Saponins are usually removed before the seed is sold. Whether a package is pre-rinsed can be checked on the label; no source read gives home rinsing advice, so follow the package directions. 9
| Body | Action | Date |
|---|---|---|
| FDA (US Food and Drug Administration) (United States) | Gluten-free labelling: any grain other than wheat, rye, barley or their hybrids can be labelled gluten-free if unavoidable gluten from cross-contact is below 20 ppm. source | 2022-06-30 |
| NIDDK (US National Institute of Diabetes and Digestive and Kidney Diseases) (United States) | Lists quinoa flour among gluten-free flours that are safe to eat; warns about cross-contact; says gluten-free labelled foods must contain less than 20 ppm gluten. source | 2020-10 |
| Celiac Disease Foundation (United States) | Lists quinoa among naturally gluten-free foods; advises tested grains under 20 ppm and no bulk bins. source | not read |
When to get medical help
- Trouble breathing, swelling of the lips, face or throat, widespread hives, repeated vomiting or collapse after eating: call emergency services (MedlinePlus advises calling 911 for anaphylaxis symptoms)
- Wheezing, dizziness or throat tightness soon after a quinoa meal: stop eating and get medical help
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
Is quinoa a grain?
Is quinoa gluten-free?
Does quinoa lower blood sugar?
Possibly a little. A pooled analysis of 7 small trials reported a beneficial effect on fasting glucose, and a one-year trial in adults with impaired glucose tolerance found better blood sugar measures than with mixed grains. A 4-week trial against rice and bulgur found no difference between groups. It is not a treatment for diabetes.
Does quinoa lower cholesterol?
Does quinoa help with weight loss?
Can you be allergic to quinoa?
Yes, though it seems rare. Case reports describe anaphylaxis to quinoa, and allergy reviews list quinoa among pseudograins that are becoming more frequent food allergens. No figure for how common it is was found. For trouble breathing or swelling of the face or throat, call emergency services.
What are saponins and are they harmful?
Saponins are the bitter coating on quinoa seeds, and they are typically removed before the seed is sold. A 2026 review says they have been called antinutritional, and reports no adverse effects in living animals below 50 mg/kg of body weight a day. That work is on extracts. No source read describes harm from prepared quinoa.
Do I need to rinse quinoa?
Saponins give a bitter taste and are usually removed before sale. We did not read a source on home rinsing, so check the label to see whether the quinoa is pre-washed and follow the package directions.
Is quinoa better than rice?
One 4-week trial in 148 adults with overweight or obesity found no significant difference in body measures, blood pressure, blood sugar or blood fats between quinoa, buckwheat, rice and bulgur. Within the quinoa group, fat mass fell and some results differed by sex.
Is quinoa safe with medicines?
No source read names a medicine interaction with quinoa. Cooked quinoa has no vitamin K listed by USDA. Ask your clinic about big diet changes if you take diabetes medicine or warfarin.
Is quinoa OK with kidney disease?
Ask your kidney team. Cooked quinoa has 172 mg of potassium and 152 mg of phosphorus per 100 g by USDA data. No quinoa-specific kidney source was read.
Is quinoa safe in pregnancy or for young children?
No quinoa-specific statement from an official body was read, and choking risk and allergy for young children were not researched. Ask your doctor, midwife or dietitian about your own diet.
Explore by health goal
Digestive SupportHeart HealthBlood Sugar BalanceCholesterol BalanceHealthy WeightMicrobiome BalanceInflammation BalanceHealthy Aging
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-26
- Last substantive update
- 2026-10-26
- How we research
- We started from our existing quinoa summary, re-checked nutrition against USDA FoodData Central data, re-read the Celiac Disease Foundation, NIDDK, FDA and MedlinePlus pages and re-read PubMed abstracts for reviews, trials and allergy reports. Only abstracts (or titles, for four case reports) were read for studies. Items we could not verify are flagged in the research gaps.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown.
Sources 26
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Astier C, Moneret-Vautrin DA, Puillandre E, Bihain BE. First case report of anaphylaxis to quinoa, a novel food in France.. Allergy. 2009. PMID 19220209. DOI 10.1111/j.1398-9995.2009.01980.x. (title-only (no abstract))
- Atefi M, Heidari Z, Shojaei M, et al.. Does Quinoa (Chenopodium quinoa) Consumption Improve Blood Glucose, Body Weight and Body Mass Index? A Systematic Review and Dose-Response Meta-Analysis of Clinical Trials.. Curr Med Chem. 2024. PMID 36847233. DOI 10.2174/0929867330666230227151852. (abstract)
- Aune D, Keum N, Giovannucci E, et al.. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.. BMJ. 2016. PMID 27301975. DOI 10.1136/bmj.i2716. (abstract)
- Cuervo-Pardo L, Gonzalez-Estrada A, Fernandez J. Anaphylaxis after home-made quinoa dinner: hold the mustard.. BMJ Case Rep. 2015. PMID 25733093. DOI 10.1136/bcr-2014-208980. (title-only (no abstract))
- Filho AM, Pirozi MR, Borges JT, et al.. Quinoa: Nutritional, functional, and antinutritional aspects.. Crit Rev Food Sci Nutr. 2017. PMID 26114306. DOI 10.1080/10408398.2014.1001811. (abstract)
- Hong J, Convers K, Reeves N, Temprano J. Anaphylaxis to quinoa.. Ann Allergy Asthma Immunol. 2013. PMID 23244665. DOI 10.1016/j.anai.2012.10.016. (title-only (no abstract))
- Huang L, Li X, Zou M, et al.. Quinoa is more effective than other whole grains in the management of impaired glucose tolerance: a randomized controlled trial.. Food Funct. 2025. PMID 39784492. DOI 10.1039/d4fo04557b. (abstract)
- Karimian J, Abedi S, Shirinbakhshmasoleh M, et al.. The effects of quinoa seed supplementation on cardiovascular risk factors: A systematic review and meta-analysis of controlled clinical trials.. Phytother Res. 2021. PMID 33037704. DOI 10.1002/ptr.6901. (abstract)
- Karydogianni S, Roussis I, Chatzitriantafyllou M, et al.. Quinoa (Chenopodium quinoa Willd.) Saponins and Their Pharmaceutical Potential: A Review.. Int J Mol Sci. 2026. PMID 42589336. DOI 10.3390/ijms27156679. (abstract)
- Leonhardt A, Glatzel V, Mastnik S, Kuna AC, Oppel EM. [Superfood sensitization-two cases of a quinoa allergy].. Dermatologie (Heidelb). 2026. PMID 42811216. DOI 10.1007/s00105-026-05693-3. (title-only (no abstract))
- Li L, Houghton D, Lietz G, et al.. Impact of Daily Consumption of Whole-Grain Quinoa-Enriched Bread on Gut Microbiome in Males.. Nutrients. 2022. PMID 36432574. DOI 10.3390/nu14224888. (abstract)
- Lindenmayer LA, Mayer MJ, Schmoeckel SM, Frank J. Saponins Do Not Impede the Bioaccessibility of Minerals and Fat-Soluble Vitamins from Different Quinoa Genotypes.. J Agric Food Chem. 2026. PMID 42030452. DOI 10.1021/acs.jafc.6c01729. (abstract)
- Malek Mahdavi A, Javadivala Z, Khalili Y, Khalili M. Effects of Quinoa (Chenopodium quinoa) on inflammatory mediators: a systematic review of preclinical studies.. Inflammopharmacology. 2023. PMID 36331709. DOI 10.1007/s10787-022-01091-y. (abstract)
- Oztekin Y, Gonen-Colak B, Tekin S, et al.. Comparative Effects of Quinoa, Buckwheat, Bulgur, and Rice on Cardiometabolic Health in Adults with Overweight or Obesity: A Randomized Controlled Study.. Metabolites. 2026. PMID 42783753. DOI 10.3390/metabo16090628. (abstract)
- Pourshahidi LK, Caballero E, Osses A, et al.. Modest improvement in CVD risk markers in older adults following quinoa (Chenopodium quinoa Willd.) consumption: a randomized-controlled crossover study with a novel food product.. Eur J Nutr. 2020. PMID 31919583. DOI 10.1007/s00394-019-02169-0. (abstract)
- Präger L, Simon JC, Treudler R. Food allergy - New risks through vegan diet? Overview of new allergen sources and current data on the potential risk of anaphylaxis.. J Dtsch Dermatol Ges. 2023. PMID 37723909. DOI 10.1111/ddg.15157. (abstract)
- Treudler R. Emerging and Novel Elicitors of Anaphylaxis: Collegium Internationale Allergologicum Update 2024.. Int Arch Allergy Immunol. 2024. PMID 38527454. DOI 10.1159/000537958. (abstract)
- Zevallos VF, Ellis HJ, Suligoj T, Herencia LI, Ciclitira PJ. Variable activation of immune response by quinoa (Chenopodium quinoa Willd.) prolamins in celiac disease.. Am J Clin Nutr. 2012. PMID 22760575. DOI 10.3945/ajcn.111.030684. (abstract)
- Zevallos VF, Herencia LI, Chang F, et al.. Gastrointestinal effects of eating quinoa (Chenopodium quinoa Willd.) in celiac patients.. Am J Gastroenterol. 2014. PMID 24445568. DOI 10.1038/ajg.2013.431. (abstract)
- . Celiac Disease Foundation: Gluten-free foods. . . (full-text)
- . FDA: Questions and Answers: Gluten-Free Food Labeling Final Rule. . . (full-text)
- . GBIF Backbone: Chenopodium quinoa Willd. (usageKey 3083935). . . (full-text)
- . MedlinePlus: Food allergy. . . (full-text)
- . NIDDK: Eating, diet, and nutrition for celiac disease. . . (full-text)
- . USDA FoodData Central: Quinoa, uncooked (FDC 168874). . . (full-text)
- . USDA FoodData Central: Quinoa, cooked (FDC 168917). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- Whole grain listed first, with no added sugar
- Gluten-free labeling if you need it, since cross-contact is common
- A best-by date and airtight storage
- Allergen statements
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.